Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jun;25(4):e14021.
doi: 10.1111/petr.14021. Epub 2021 Apr 7.

Prophylactic antithrombotic management in adult and pediatric kidney transplantation: A systematic review and meta-analysis

Sascha Bapistella  1 , Matthias Zirngibl  1 , Kathrin Buder  2 , Nikan Toulany  1 , Guido F Laube  3 , Marcus Weitz  1
Affiliations
Free article
Meta-Analysis

Prophylactic antithrombotic management in adult and pediatric kidney transplantation: A systematic review and meta-analysis

Sascha Bapistella et al. Pediatr Transplant. 2021 Jun.
Free article

Abstract

Background: RGT is a major cause for early graft loss after KTx. Although evidence-based recommendations are lacking, aP is often used to prevent RGT. This systematic review aimed to determine the effectiveness and safety of aP in adult and pediatric KTx recipients.

Methods: MEDLINE, EMBASE, Cochrane Controlled Trials Register, conference proceedings, and electronic databases for trial registries were searched for eligible studies using search terms relevant to this review (April 21, 2020). The systematic review was carried out following the recommendations of the Cochrane Collaboration and the Prefered Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement.

Results: Twelve studies comprising 2370 patients (adult = 1415, pediatric = 955) were included, of which three were RCTs. The overall risk for developing RGT was lower in the group with aP compared with the control group (RR 0.24, 95% confidence interval 0.12-0.49). The antithrombotic drugs used were heparin (7/12), acetylsalicylic acid (2/12), a combination of both (2/12), and dipyridamole (1/12) with a high variability in timing, dosing, and mode of application. Adverse effects were reported rarely, with minor bleeding as the main complication. The non-randomized studies had significant risks of bias in the domains of patient selection, confounder, and measurement of outcomes.

Conclusion: Based on pooled analysis, aP seems to reduce the risk of RGT in KTx. However, the reliability of these results is limited, as the quality of the available studies is poor and information on adverse effects associated with aP is scarce. Additional high-quality research is urgently needed to provide sufficient data supporting the use of aP in KTx.

Keywords: antithrombotic prophylaxis; kidney transplantation; renal graft thrombosis; systematic review; thrombosis.

PubMed Disclaimer

References

REFERENCES

    1. Berg TAJ, Minnee RC, Lisman T, et al. Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation - a retrospective study. Transpl Int. 2019;32(4):418-430.
    1. Poli D, Antonucci E, Zanazzi M. Hemostatic complications in renal transplantation. Semin Thromb Hemost. 2017;43(7):742-749.
    1. Smith JM, Stablein D, Singh A, Harmon W, McDonald RA. Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: a report of the NAPRTCS. Am J Transplant. 2006;6(3):585-588.
    1. Chua A, Cramer C, Moudgil A, et al. Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS. Pediatr Transplant. 2019;23(8):e13597.
    1. Gander R, Asensio M, Royo GF, et al. Vascular thrombosis in pediatric kidney transplantation: Graft survival is possible with adequate management. J Pediatr Urol. 2018;14(3):222-230.

Substances